Pulmonary nodule overview: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:


==Causes==
==Causes==
Causes of solitary pulmonary nodule, can be classified into 5 categories: infectious, neoplastic, inflammatory, immunological, vascular and miscellaneous.  Common causes, include:  
Causes of solitary pulmonary nodule, can be classified into 5 categories: infectious, neoplastic, inflammatory, immunological, vascular and miscellaneous.  Common causes, include: tuberculosis, primary lung cancer, granulomas, rheumatic nodule, and pulmonary abscess.


==Differentiating Solitary Pulmonary Nodule from Other Diseases==
==Differentiating Solitary Pulmonary Nodule from Other Diseases==

Revision as of 17:44, 15 March 2016

Pulmonary Nodule Microchapters

Home

Patient Information

Overview

Classification

Causes

Differentiating Pulmonary Nodule from Other Diseases

Epidemiology and Demographics

Screening

Natural history, Complications and Prognosis

Diagnosis

Evaluation of Solitary Pulmonary Nodule

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Pulmonary nodule overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary nodule overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary nodule overview

CDC on Pulmonary nodule overview

Pulmonary nodule overview in the news

Blogs on Pulmonary nodule overview

Directions to Hospitals Treating Solitary pulmonary nodule

Risk calculators and risk factors for Pulmonary nodule overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Solitary pulmonary nodule (SPN) is defined as a relatively well defined round or oval pulmonary parenchymal lesion equal or smaller than 30 mm in diameter. Solitary pulmonary nodule is usually surrounded by pulmonary parenchyma and/or visceral pleura and is not associated with lymphadenopathy, atelectasis, or pneumonia. In the majority of the cases, solitary pulmonary nodule can be encountered as a incidental finding.[1][2] The nodule most commonly represents a benign tumor, such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer.[2] Approximately 10 to 20% of patients with lung cancer are initially diagnosed with solitary pulmonary nodule.[2] The possibility of cancer needs to be ruled out through further radiological studies and interventions. The prognosis of solitary pulmonary nodule depend on the underlying conditions.

Classification

According to the Fleischner Society, solitary pulmonary nodules may be classified according to size, morphology, and/or distribution (multiple/single).

Causes

Causes of solitary pulmonary nodule, can be classified into 5 categories: infectious, neoplastic, inflammatory, immunological, vascular and miscellaneous. Common causes, include: tuberculosis, primary lung cancer, granulomas, rheumatic nodule, and pulmonary abscess.

Differentiating Solitary Pulmonary Nodule from Other Diseases

Solitary pulmonary nodule may be differentiated according to imaging (size, border characteristics, and attenuation), histological, and clinical features, from other diseases that demonstrate similar imaging findings. Common differential diagnosis of solitary pulmonary nodule, include: hamartoma, granulomas, rheumatic nodule, and single metastasis

Epidemiology and Demographics

Solitary pulmonary nodules are common. The prevalence of solitary pulmonary nodule ranges between 8-51%. The incidence rate of solitary pulmonary nodule is approximately 45 per 100 000 individuals in the United States. The incidence of solitary pulmonary nodule increases with age, tobacco use, and prior cancer; the median age at diagnosis is between. Males are more commonly affected with lung masses than females. The male to female ratio is approximately 2 to 1.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for solitary pulmonary nodule.[3][4]

Diagnosis

History and Symptoms

Solitary pulmonary nodules are generally asymptomatic. The majority of patients may develop non-specific symptoms, such as: dyspnea, hemoptysis, chronic coughing, wheezing, and chest pain. Obtaining the detailed history can be an important aspect of making a diagnosis of solitary pulmonary nodule, specific areas of focus when obtaining the history, include: previous infection of tuberculosis, previous or current smoking history, history of immunological conditions, high occupational risk profession, or recent traveling.[5]

Physical Examination

Patients with solitary pulmonary nodule usually are well-appearing. Physical examination of patients with solitary pulmonary nodule usually has no remarkable findings. In some cases, solitary pulmonary nodule may show some findings associated with the underlying condition.

Laboratory Findings

There are no diagnostic laboratory findings associated with solitary pulmonary nodule.

Imaging

Conventional radiography is the initial method of choice for the diagnosis of solitary pulmonary nodule. The evaluation and risk assessment of solitary pulmonary nodule will depend on several characteristics, such as: size, growth, shape, margin, air bronchogram sign, and attenuation. Further evaluation of solitary pulmonary lung nodule, should include enhanced CT scan or MRI imaging. Other imaging studies include PET scanning, which may be useful as a staging modality, detection of occult disease, and malignancy assessment.

Other Diagnostic Studies

Treatment

Therapeutic Management

References

  1. Ost D, Fein AM, Feinsilver SH (2003). "Clinical practice. The solitary pulmonary nodule". N. Engl. J. Med. 348 (25): 2535–42. doi:10.1056/NEJMcp012290. PMID 12815140. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 2.2 Alzahouri K, Velten M, Arveux P, Woronoff-Lemsi MC, Jolly D, Guillemin F (2008). "Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts". BMC Cancer. 8: 93. doi:10.1186/1471-2407-8-93. PMC 2373300. PMID 18402653.
  3. Recommendations. US preventive services task force(2016) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=solitary_pulmonary_nodule Accessed on March, 15th 2016
  4. McWilliams A, Tammemagi MC, Mayo JR, et. al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013 Sep 5;369(10):910-9. doi:10.1056/NEJMoa1214726.
  5. Hakim DN, Pelly T, Kulendran M, Caris JA (2015). "Benign tumours of the bone: A review". J Bone Oncol. 4 (2): 37–41. doi:10.1016/j.jbo.2015.02.001. PMC 4620948. PMID 26579486.


Template:WikiDoc Sources